Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2565400rdf:typepubmed:Citationlld:pubmed
pubmed-article:2565400lifeskim:mentionsumls-concept:C0040615lld:lifeskim
pubmed-article:2565400lifeskim:mentionsumls-concept:C0039593lld:lifeskim
pubmed-article:2565400lifeskim:mentionsumls-concept:C0022885lld:lifeskim
pubmed-article:2565400lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:2565400lifeskim:mentionsumls-concept:C0005456lld:lifeskim
pubmed-article:2565400lifeskim:mentionsumls-concept:C1523689lld:lifeskim
pubmed-article:2565400lifeskim:mentionsumls-concept:C1510827lld:lifeskim
pubmed-article:2565400lifeskim:mentionsumls-concept:C1709630lld:lifeskim
pubmed-article:2565400lifeskim:mentionsumls-concept:C0772162lld:lifeskim
pubmed-article:2565400lifeskim:mentionsumls-concept:C0070698lld:lifeskim
pubmed-article:2565400pubmed:issue5lld:pubmed
pubmed-article:2565400pubmed:dateCreated1989-6-6lld:pubmed
pubmed-article:2565400pubmed:abstractTextGenerally, antipsychotic agents are dopamine receptor blocking agents that also block conditioned avoidance responding (CAR) in the rat. Recently, however, both (Q-methoxyphenyl)piperazine (OMPP, 1h) and (m-chlorophenyl)piperazine (MCPP, 1o) have been reported to block conditioned avoidance responding in the rat although neither has dopamine receptor blocking properties. The present paper examines the behavioral and biochemical profile of a number of additional substituted phenylpiperazines. None of the phenylpiperazines tested demonstrated high affinity for either dopamine D-1 or D-2 receptor sites, yet many were effective in blocking CAR. The results suggest that the phenylpiperazines may be effective antipsychotic agents without blocking dopamine receptors. Moreover, the active compounds did demonstrate activity in displacing ligand binding to serotonin receptors. Receptor binding profiles were determined for 5-HT-1A and 5-HT-1B binding sites as well as for 5-HT-2 sites. The data from this preclinical test suggest these phenylpiperazines might be effective antipsychotic agents acting via a nondopaminergic mechanism of action.lld:pubmed
pubmed-article:2565400pubmed:languageenglld:pubmed
pubmed-article:2565400pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2565400pubmed:citationSubsetIMlld:pubmed
pubmed-article:2565400pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2565400pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2565400pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2565400pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2565400pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2565400pubmed:statusMEDLINElld:pubmed
pubmed-article:2565400pubmed:monthMaylld:pubmed
pubmed-article:2565400pubmed:issn0022-2623lld:pubmed
pubmed-article:2565400pubmed:authorpubmed-author:ShankR PRPlld:pubmed
pubmed-article:2565400pubmed:authorpubmed-author:MartinG EGElld:pubmed
pubmed-article:2565400pubmed:authorpubmed-author:ScottM KMKlld:pubmed
pubmed-article:2565400pubmed:authorpubmed-author:MathiasenJ...lld:pubmed
pubmed-article:2565400pubmed:authorpubmed-author:ElginR JRJJrlld:pubmed
pubmed-article:2565400pubmed:authorpubmed-author:KesslickJ MJMlld:pubmed
pubmed-article:2565400pubmed:authorpubmed-author:BaldyW JWJlld:pubmed
pubmed-article:2565400pubmed:authorpubmed-author:DiStefanoD...lld:pubmed
pubmed-article:2565400pubmed:authorpubmed-author:FeddeC LCLlld:pubmed
pubmed-article:2565400pubmed:authorpubmed-author:DavisC BCBlld:pubmed
pubmed-article:2565400pubmed:issnTypePrintlld:pubmed
pubmed-article:2565400pubmed:volume32lld:pubmed
pubmed-article:2565400pubmed:ownerNLMlld:pubmed
pubmed-article:2565400pubmed:authorsCompleteYlld:pubmed
pubmed-article:2565400pubmed:pagination1052-6lld:pubmed
pubmed-article:2565400pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:2565400pubmed:meshHeadingpubmed-meshheading:2565400-...lld:pubmed
pubmed-article:2565400pubmed:meshHeadingpubmed-meshheading:2565400-...lld:pubmed
pubmed-article:2565400pubmed:meshHeadingpubmed-meshheading:2565400-...lld:pubmed
pubmed-article:2565400pubmed:meshHeadingpubmed-meshheading:2565400-...lld:pubmed
pubmed-article:2565400pubmed:meshHeadingpubmed-meshheading:2565400-...lld:pubmed
pubmed-article:2565400pubmed:meshHeadingpubmed-meshheading:2565400-...lld:pubmed
pubmed-article:2565400pubmed:meshHeadingpubmed-meshheading:2565400-...lld:pubmed
pubmed-article:2565400pubmed:meshHeadingpubmed-meshheading:2565400-...lld:pubmed
pubmed-article:2565400pubmed:meshHeadingpubmed-meshheading:2565400-...lld:pubmed
pubmed-article:2565400pubmed:year1989lld:pubmed
pubmed-article:2565400pubmed:articleTitleActivity of aromatic substituted phenylpiperazines lacking affinity for dopamine binding sites in a preclinical test of antipsychotic efficacy.lld:pubmed
pubmed-article:2565400pubmed:affiliationDepartment of Biological Research, McNeil Pharmaceutical and Janssen Research Foundation Worldwide, Spring House, Pennsylvania 19477.lld:pubmed
pubmed-article:2565400pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:2565400lld:chembl